COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation

Shiyu Yang, Xia Lin, Wen Liu, Xiwei Hu

Open source

DOI
10.1186/s12920-026-02446-y
Published
2026-08-05
Container
BMC Medical Genomics
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12920-026-02446-y,
  title = {COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation},
  author = {Shiyu Yang and Xia Lin and Wen Liu and Xiwei Hu},
  year = {2026},
  journal = {BMC Medical Genomics},
  doi = {10.1186/s12920-026-02446-y},
  url = {https://doi.org/10.1186/s12920-026-02446-y}
}

RIS

TY  - JOUR
TI  - COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation
AU  - Shiyu Yang
AU  - Xia Lin
AU  - Wen Liu
AU  - Xiwei Hu
PY  - 2026
JO  - BMC Medical Genomics
DO  - 10.1186/s12920-026-02446-y
UR  - https://doi.org/10.1186/s12920-026-02446-y
ER  - 

APA

Yang, S., Lin, X., Liu, W., & Hu, X. (2026). COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation. BMC Medical Genomics. https://doi.org/10.1186/s12920-026-02446-y

Source records